Lupeol Pulvis XCVIII%

Description:

Pulvis lupeol est nova puritate triterpene.Lupeol is a Brand-new androgen receptor blocker.

Lupeol (Clerodol; Monogynol B; Fagarasterol) est triterpene activum pentacyclicum cum antioxidante, antitumore et anti-inflammatione actionis.Lupeol receptor inhibitor androgen potens est et in investigationibus canceris adhiberi potest, praesertim in cancro prostatae cum phaenotypo androgen-dependens (ADPC) et phaenotypo castrationis repugnans (CRPC).


  • MALITIA Price:US $0.5 - 2000 / KG
  • Min.Order Quantitas:1 KG
  • Facultates copia:(X) KG/per Month
  • Portus:SHANGHAI / BEIJING
  • Pensio conditio:L/C,D/A,D/P,T/T
  • :
  • Product Detail

    Product Tags

    Product nomen:Lupeol Pulvis98%

    Botanical Source: Mango, Acacia visco, Abronia villosa, APHACA capulus.

    CASNo:545-47-1

    Color:Alba ut off-albapulveris cum ratione odoris et saporis

    Specification: ≥98% HPLC

    GMOStatus: GMO Free

    Stipare: in 25kgs fibra tympana

    Repono: Contine vas pervium in loco frigido, loco sicco, prohibe a luce firma

    Shelf Life: 24 months from the date of production

    Actio biologica:

    Lupeol (Clerodol; Monogynol B; Fagarasterol) est triterpenoideum activum pentacyclicum, habet anti-oxidant, anti-mutagenicum, anti-tumorem et actionem inflammatoriam.Lupeol est potensandrogen receptor(AR) inhibitor et adhiberi potestcancerinvestigatio, praesertim prostataecancerphaenotypi androgeni-dependens (ADPC) et castrationis phaenotypi resistentis (CRPC) [1].

     

    In vitro Investigatio:

    Lupeolor est potens AR inhibitor qui enucleari potest ut medicamentum potentiale ad cancrum prostatae humani curationis (CaP).Lupeol (10-50 µM) curatio pro 48 h consecuta est in inhibitionis dosi-dependens incrementum phaenotypi androgeni-dependens (ADPC) cellularum, nempe LAPC4 et LNCaP cellulas, cum IC50 15.9 et 17.3 µM, respective.Lupeol quoque incrementum 22Rν_1 cum IC50 19.1 μM inhibuit.Praeterea Lupeol incrementum cellularum C4-2b cum IC50 25 μM inhibuit.Lupeol potentia inhibere incrementum cellularum CaP tum ADPC et CRPC phaenotyporum habet.Androgens notum est incrementum Cellulae Cap per activationem AR[1] agere.

     

    In Vivo Research:

    Lupeol medicamentum efficax est cum potentia ad inhibendam tumorigenicitatem cellularum in vivo Cap.Totalis serum PSA graduum circulantium (ab cellulis tumore insitis secretis) in fine studiorum die metiebatur 56. Ad diem 56 post-implantationem, PSA gradus ab 11.95-12.79 ng/mL observati sunt in moderandis animalibus cum tumoribus et LNCaP tumores C4-2b, resp.Autem, Lupeol-tractatus versos exhibebat reductos serum PSA graduum vndique a 4.25-7.09 ng/mL.Fibras tumoris ex animalibus cum Lupeol tractatis exhibitas serum PSA graduum reductorum ad moderamina comparata [1].

     

     


  • Priora:
  • Deinde: